Oil produced by the pyrolysis of biomass and co-pyrolysis of biomass with waste synthetic polymers has significant potential as a substitute for fossil fuels. However, the relatively poor properties found in pyrolysis oil—such as high oxygen content, low caloric value, and physicochemical instability—hampers its practical utilization as a commercial petroleum fuel replacement or additive. This review focuses on pyrolysis catalyst design, impact of using real waste feedstocks, catalyst deactivation and regeneration, and optimization of product distributions to support the production of high value-added products. Co-pyrolysis of two or more feedstock materials is shown to increase oil yield, caloric value, and aromatic hydrocarbon content. In addition, the co-pyrolysis of biomass and polymer waste can contribute to a reduction in production costs, expand waste disposal options, and reduce environmental impacts. Several promising options for catalytic pyrolysis to become industrially viable are also discussed.

Due to the theragnostic potential of mesoporous silica nanoparticles (MSNs), these were extensively investigated as a novel approach to improve clinical outcomes. Boasting an impressive array of formulations and modifications, MSNs demonstrate significant in vivo efficacy when used to identify or treat myriad malignant diseases in preclinical models. As MSNs continue transitioning into clinical trials, a thorough understanding of the characteristics of effective MSNs is necessary. This review highlights recent discoveries and advances in MSN understanding and technology. Specific focus is given to cancer theragnostic approaches using MSNs. Characteristics of MSNs such as size, shape, and surface properties are discussed in relation to effective nanomedicine practice and projected clinical efficacy. Additionally, tumor-targeting options used with MSNs are presented with extensive discussion on active-targeting molecules. Methods for decreasing MSN toxicity, improving site-specific delivery, and controlling release of loaded molecules are further explained. Challenges facing the field and translation to clinical environments are presented alongside potential avenues for continuing investigations.